Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 9 results.
User Information
Export Records
  1. 1.   Acute Retroviral Syndrome is Associated with High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments
  2. Crowell, Trevor A; Colby, Donn J; Pinyakorn, Suteeraporn; Fletcher, James L K; Kroon, Eugène; Schuetz, Alexandra; Krebs, Shelly J; Slike, Bonnie M; Leyre, Louise; Chomont, Nicolas; Jagodzinski, Linda L; Sereti, Irini; Utay, Netanya S; Dewar, Robin; Rerknimitr, Rungsun; Chomchey, Nitiya; Trichavaroj, Rapee; Valcour, Victor G; Spudich, Serena; Michael, Nelson L; Robb, Merlin L; Phanuphak, Nittaya; Ananworanich, Jintanat
  3. Clinical Infectious Diseases. 2018, May 15; 66(10): 1540-1549.
  1. 2.   Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation
  2. Crowell, T. A.; Fletcher, J. L.; Sereti, I.; Pinyakorn, S.; Dewar, R.; Krebs, S. J.; Chomchey, N.; Rerknimitr, R.; Schuetz, A.; Michael, N. L.; Phanuphak, N.; Chomont, N.; Ananworanich, J.
  3. Journal of the International Aids Society. 2016 19(1): 21163.
  1. 3.   Eradication of HIV in infected patients: Some potential approaches
  2. Yang, Q. E.
  3. Medical Science Monitor. 2004, JUL; 10(7): RA155-RA165.
  1. 4.   A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types
  2. Lueders, K. K.; De Rosa, S. C.; Valentin, A.; Pavlakis, G. N.; Roederer, M.; Hamer, D. H.
  3. Aids Research and Human Retroviruses. 2004 20(2): 145-150.
  1. 5.   Human immunodeficiency virus reservoir might be actively eradicated as residual malignant cells by cytotoxic chemotherapy
  2. Yang, Q.
  3. Medical Hypotheses. 2004 62(3): 358-363.
  1. 6.   Peptide nucleic acids as epigenetic inhibitors of HIV-1
  2. Sei, S.
  3. Letters in Peptide Science. 2003 10(3-4): 269-286.
  1. 7.   Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study
  2. Yamashita, T. E.; Phair, J. P.; Munoz, A.; Margolick, J. B.; Detels, R.; O'Brien, S. J.; Mellors, J. W.; Wolinsky, S. M.; Jacobson, L. P.
  3. Aids. 2001 15(6): 735-746.
  1. 8.   Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV
  2. Kovacs, J. A.; Lempicki, R. A.; Sidorov, I. A.; Adelsberger, J. W.; Herpin, B.; Metcalf, J. A.; Sereti, I.; Polis, M. A.; Davey, R. T.; Tavel, J.; Falloon, J.; Stevens, R.; Lambert, L.; Dewar, R.; Schwartzentruber, D. J.; Anver, M. R.; Baseler, M. W.; Masur, H.; Dimitrov, D. S.; Lane, H. C.
  3. Journal of Experimental Medicine. 2001 194(12): 1731-1741.
  1. 9.   Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression
  2. Hatano, H.; Vogel, S.; Yoder, C.; Metcalf, J. A.; Dewar, R.; Davey, R. T.; Polis, M. A.
  3. Aids. 2000 14(10): 1357-1363.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel